#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15908	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2141	737.1	0	.	n	.	0	C451T	SNP	451	451	C	718	718	T	875	T,C	450,382	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15908	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2141	737.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1451	1451	C	897	C	857	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15908	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2141	737.1	0	HET	.	.	.	C207T	.	207	207	C	474	474	C	919	C,T	682,178	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28812	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	812.6	0	.	n	.	0	T695C	SNP	695	695	T	959	959	C	900	C,T,A	853,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28812	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	812.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2235	2235	C	870	C	814	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28812	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	812.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2309	2309	A	880	A	830	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28812	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	812.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2861	2861	C	810	C	766	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28812	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3530	812.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1902	1902	A	928	A,G	482,409	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2096	folP	855	855	100.0	folP.l15.c4.ctg.1	1573	132.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1105	1107	AGC	197;197;196	A;G;C	190;188;184	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5468	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3480	156.5	1	SNP	p	S91F	1	.	.	271	273	TTC	533	535	TTC	202;203;205	T;T,C;C	194;193,1;196	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5468	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3480	156.5	1	SNP	p	G95N	0	.	.	283	285	GGC	545	547	GGC	203;203;204	G;G,A;C	192;192,1;196	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5468	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3480	156.5	1	SNP	p	D95G	1	.	.	283	285	GGC	545	547	GGC	203;203;204	G;G,A;C	192;192,1;196	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1686	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1340	125.2	1	SNP	p	G45D	0	.	.	133	135	GGC	468	470	GGC	202;206;206	G;G,A;C	193;194,1;195	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	930	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1029	89.1	0	.	n	.	0	A197.	DEL	197	197	A	625	625	A	213	A	201	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6098	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3022	201.1	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	259;261;258	G,A;A;C	249,1;243;247	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6098	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3022	201.1	1	SNP	p	R87W	0	.	.	259	261	CGT	621	623	CGT	258;259;259	C;G;T	249;247;252	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6098	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3022	201.1	1	SNP	p	S87R	1	.	.	259	261	CGT	621	623	CGT	258;259;259	C;G;T	249;247;252	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6098	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3022	201.1	1	SNP	p	R87I	0	.	.	259	261	CGT	621	623	CGT	258;259;259	C;G;T	249;247;252	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6098	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3022	201.1	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	258;257;260	T,C;C;C,A	249,1;247;246,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4514	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2654	169.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	248;247;247	G;G;C	235;232;231	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1145	1147	GCC	211;210;211	G,C;C;C	195,1;197;196	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1148	1150	ATG	213;215;217	A;T;G	198;198;201	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1160	1162	ACC	207;205;206	A,T;C;C	189,1;189;193	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1160	1162	ACC	207;205;206	A,T;C;C	189,1;189;193	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1661	1663	ACC	218;220;220	A;C;C	196;202;203	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1715	1717	GCG	239;236;235	G;C;G	221;216;218	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1715	1717	GCG	239;236;235	G;C;G	221;216;218	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1838	1840	GGT	171;170;168	G;G;T	159;159;155	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1847	1849	AGC	166;163;163	A;G;C	154;153;152	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4142	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2199	186.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1865	1867	CCG	147;147;147	C,CG;C;G,T	110,1;114;116,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6294	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3084	203.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1619	1621	CCG	216;217;217	C;C;G	196;209;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2664	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1976	134.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	669	669	C	200	C,A	185,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3114	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1579	195.4	1	SNP	p	G120K	1	.	.	358	360	AAG	686	688	AAG	239;231;232	A;A;G,C	224;221;214,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3114	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1579	195.4	1	SNP	p	A121N	1	.	.	361	363	AAC	689	691	AAC	231;232;233	A,G;A;C	216,1;220;218	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3114	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1579	195.4	1	SNP	p	N121D	0	.	.	361	363	AAC	689	691	AAC	231;232;233	A,G;A;C	216,1;220;218	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11334	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5053	223.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1220	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	995	121.0	1	SNP	p	V57M	1	.	.	169	171	ATG	490	492	ATG	248;248;250	A,G;T;G	233,1;230;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
